Your ACL Graft: Autograft, Allograft, and Why Blood Supply Matters

When you tear your ACL, the ligament doesn't heal back on its own — it simply doesn't have the blood supply for that. So when we reconstruct it, we replace the torn ligament with a graft: a strip of tissue that takes over the ACL's job while your body slowly turns it into a living ligament. One of the questions I get asked most often in clinic is deceptively simple — what should my new ACL actually be made of? Let me walk you through how I think about it.

Ruling out synthetic grafts, and a note on xenografts

Years ago, synthetic grafts — man-made ligament substitutes such as LARS (Ligament Augmentation and Reconstruction System) — were tried widely. They still have a role in a few places today, including parts of China and Italy, largely because they allow for immediate mechanical stability and a faster return to activity.¹ But the wider international sports surgery community has moved away from them. The concern isn't the initial strength — it's what happens over years, with reported synovitis and long-term failure rates that vary widely between studies. For most patients, I don't consider synthetic grafts a first-line option today.

There's also a more experimental idea worth mentioning honestly, even though it isn't something I offer: the xenograft — a graft taken from animal tissue rather than human tissue, most often specially processed porcine (pig) tendon. Xenograft tissue triggers a genuine immune rejection risk in humans, driven mainly by a sugar molecule on animal cells called alpha-galactosyl, so it has to go through extensive processing to strip that out before it's safe to implant. One such processed device, the Z-Lig, was studied at the Istituto Ortopedico Rizzoli in Bologna — where I later trained under Professor Stefano Zaffagnini — as part of a small international pilot study. Early results in a handful of patients were encouraging, with good graft incorporation and no major immune reaction on follow-up testing.² But this remains genuinely experimental, based on very small numbers of patients, and it is not part of mainstream ACL practice anywhere in the world today. I mention it only because patients sometimes come across it online and ask — it isn't a real-world option at this point.

That leaves us with human tissue, and here the real decision begins: your own tissue (autograft) or tissue from a donor (allograft).

Autograft or allograft: your tissue, or someone else's

The case for autograft

An autograft is harvested from your own body — most commonly your hamstrings, quadriceps tendon, or patellar tendon. Because it's your own living tissue, there tends to be less of an inflammatory reaction and, generally, more reliable healing. This is the main reason autograft remains my default recommendation for younger, more active patients.

The trade-off is what we call donor site morbidity — every graft has to come from somewhere, and taking it isn't free. Use the hamstrings, and there can be some early weakness in knee flexion. Use the quadriceps tendon, and there can be some weakness in the extensor mechanism. Use the patellar tendon (with a bone block, hence "bone-patellar tendon-bone" or BTB), and there's a higher chance of kneeling pain or anterior knee pain afterward — reported in as many as 31% of BTB patients in some series, roughly double the rate seen after hamstring grafts.³ Most of this recovers well with rehab, but it's real, and it's worth knowing about upfront.

The case for allograft

An allograft comes from a donor — usually processed tendon from a cadaver. Its biggest advantage is that there's no harvesting from your own body, so no donor site morbidity, no risk of harvest failure, and a technically simpler, faster operation for your surgeon.

The trade-offs: allograft tissue is more expensive, and because it typically comes from an older donor, tissue quality can be more variable than a young, healthy autograft. This is why I generally reserve allograft for older, less active patients, and for revision surgery, where there may not be enough good autograft tissue left to use.

What age changes

Here's the evidence-based nuance worth knowing. Large cohort data consistently shows that in young, active patients, allografts fail considerably more often than autografts — one major US longitudinal cohort found the odds of graft rupture after allograft to be roughly four times higher than after autograft, and one of the largest ACL registries in the world, run by Kaiser Permanente, has confirmed similar patterns across tens of thousands of reconstructions.³,⁴ But as patients get older and less athletically demanding, that gap narrows meaningfully. That's the evidence base behind why age and activity level, not just personal preference, genuinely shape this decision.

Vascularized vs devascularized: the distinction I care most about

Beyond autograft and allograft, there's a second way to categorize grafts that I think matters just as much, and it's discussed far less often with patients: whether the graft keeps its blood supply intact, or not.

Vascularized grafts: still "alive" when they go in

A vascularized graft stays partly attached to its original blood supply during surgery, instead of being fully cut free and prepared on a separate table. Only two options in ACL surgery come close to this: the iliotibial band (ITB), used in Lemaire/MacIntosh-type techniques (though we don't actually have strong proof it stays "alive"), and the hamstring graft left attached at the pes anserinus — its natural attachment point on the shin bone — which does have solid proof behind it. I studied this second technique closely during my fellowship in Bologna under Professor Stefano Zaffagnini, whose own research confirmed that this attachment point has a real, working blood and nerve supply.⁵

Here's why that matters: every graft has to "come alive" inside the knee before it turns into a proper ligament, a process called ligamentization.⁶ Normally, part of the graft dies off temporarily before new blood vessels grow in and it heals into place. Grafts left attached at the pes anserinus seem to skip or shorten that die-off phase — animal studies, tissue studies, and human MRI scans all show they heal faster and more predictably than fully detached grafts.⁷⁻¹² The largest clinical trial (110 athletes, two years of follow-up) found attached grafts led to slightly tighter, more stable knees and a closer return to pre-injury sport — though the difference was small enough that the researchers didn't consider it clinically significant for any one patient.¹³ For the full evidence behind this: Vascularized vs Devascularized ACL Grafts.

Devascularized grafts: fully detached, and still the majority

Every other graft option in common use today is devascularized — fully removed from the body, prepared on a back table, and reattached with a completely new blood supply that has to grow in from scratch. This includes:

• Quadriceps tendon — a short, full-thickness segment
• Superficial rectus femoris graft — a thinner variation of the quadriceps tendon graft, increasingly popular over the last couple of years
• Detached hamstring graft — semitendinosus alone, or bundled together with gracilis; the most commonly used graft worldwide
• Bone-patellar tendon-bone (BTB) — includes a segment of bone at each end, which allows for bony union at the tunnel sites; more popular in the United States than elsewhere
• Peroneus longus autograft — taken from the ankle, used more in countries like Thailand; less common globally, but studies show good functional outcomes with minimal donor-site problems at the ankle. Interestingly, the same tendon has also been studied as a cadaveric allograft — one series of 28 patients reported excellent patient-reported outcome scores and no reoperations for graft failure at an average of over four years' follow-up, suggesting it's a viable option on the donor-tissue side too.¹⁴

Every one of these is a well-studied, well-accepted option. The devascularized hamstring graft in particular remains the workhorse graft internationally, and for good reason — it's versatile, reliable, and well understood.

So which graft is right for you?

Every graft comes with trade-offs — there's no such thing as a "free" graft. My default recommendation, especially for younger and more active patients, remains autograft. And where the anatomy allows it, I lean toward keeping the hamstring graft attached at the pes anserinus, precisely because it's the only technique we can currently prove preserves blood supply — with the biological advantages that come with it, even if the clinical gap over a standard graft is modest rather than dramatic.

But the "best" graft is never one-size-fits-all. Your age, activity level, whether this is a primary or revision surgery, and your own goals all shape the right answer for you. This is exactly the kind of decision I want to walk through with you directly, not hand you as a checklist.

I've been on both sides of a sports injury — as a competitive triathlete and runner before I was a surgeon — and I've come to believe that healing is rarely just a technical process. It's also a season that tests patience, and one I hold with faith alongside the science.

If you'd like to talk through which graft makes sense for your knee, you can start here: /acl/start.

This article was clinically authored and narrated by Dr Mok Ying Ren. AI assistance was limited to language editing and formatting.

References

1. Moretti L, Garofalo R, Cassano GD, Geronimo A, Reggente N, Piacquadio F, Bizzoca D, Solarino G. Anterior cruciate ligament reconstruction with LARS synthetic ligament: outcomes and failures. J Clin Med. 2025;14(1):32.
2. Zaffagnini S, Grassi A, Marcheggiani Muccioli GM, Roberti di Sarsina T, Raggi F, Benzi A, Marcacci M. Anterior cruciate ligament reconstruction with a novel porcine xenograft: the initial Italian experience. Joints. 2015;3(2):85-90.
3. Boyd E, Endres NK, Geeslin AG. Postoperative healing and complications based on anterior cruciate ligament reconstruction graft type. Ann Joint. 2024;9:30.
4. Maletis GB, Funahashi TT, Inacio MCS, Paxton LW. Optimizing anterior cruciate ligament reconstruction: individualizing the decision-making process using data from the Kaiser Permanente ACLR Registry: 2018 OREF award paper. J Orthop Res. 2022;40(1):29-42.
5. Zaffagnini S, Golanò P, Farinas O, Depasquale V, Strocchi R, Cortecchia S, Marcacci M, Visani A. Vascularity and neuroreceptors of the pes anserinus: anatomic study. Clin Anat. 2003;16(1):19-24.
6. Yao S, Fu BS-C, Yung PS-H. Graft healing after anterior cruciate ligament reconstruction (ACLR). Asia Pac J Sports Med Arthrosc Rehabil Technol. 2021;25:8-15.
7. Papachristou G, Nikolaou V, Efstathopoulos N, Sourlas J, Lazarettos J, Frangia K, Papalois A. ACL reconstruction with semitendinosus tendon autograft without detachment of its tibial insertion: a histologic study in a rabbit model. Knee Surg Sports Traumatol Arthrosc. 2007;15(10):1175-1180.
8. Liu S, Sun Y, Wan F, Ding Z, Chen S, Chen J. Advantages of an attached semitendinosus tendon graft in anterior cruciate ligament reconstruction in a rabbit model. Am J Sports Med. 2018;46(13):3227-3236.
9. Liu S, Li H, Tao H, Sun Y, Chen S, Chen J. A randomized clinical trial to evaluate attached hamstring anterior cruciate ligament graft maturity with magnetic resonance imaging. Am J Sports Med. 2018;46(5):1143-1149.
10. Grassi A, Casali M, Macchiarola L, Lucidi GA, Cucurnia I, Filardo G, Lopomo NF, Zaffagnini S. Hamstring grafts for anterior cruciate ligament reconstruction show better magnetic resonance features when tibial insertion is preserved. Knee Surg Sports Traumatol Arthrosc. 2020. doi:10.1007/s00167-020-05948-z.
11. Ruffilli A, Pagliazzi G, Ferranti E, Busacca M, Capannelli D, Buda R. Hamstring graft tibial insertion preservation versus detachment in anterior cruciate ligament reconstruction: a prospective randomized comparative study. Eur J Orthop Surg Traumatol. 2016;26(6):657-664.
12. Sinha S, Arumugham KC, Singh DK, Kumar N, Bera AP, Uppal H, Vakharia KS. ACL reconstruction with attachment-sparing hamstring autograft results in earlier graft maturation and better short-term clinical outcome in comparison to free graft: a randomized controlled trial. Am J Sports Med. 2026. doi:10.1177/03635465261455046.
13. Gupta R, Bahadur R, Malhotra A, Masih GD, Sood M, Gupta P, Mathur VK. Outcome of hamstring autograft with preserved insertions compared with free hamstring autograft in anterior cruciate ligament surgery at 2-year follow-up. Arthroscopy. 2017;33(12):2208-2216.
14. Wang H Jr, Aryee J, Silver J, Badalyan N, Scheer R, Gatt C. Peroneus longus allograft for anterior cruciate ligament reconstruction: a single institution experience. J Orthop Rep. 2026;5:100748.